Addressing the critical need for innovative and effective treatment in Thalassemia, Dr Sanjay Agrawal, a distinguished pharmaceutical consultant and inventor, with two decades of experience in research, has filed a patent at the Indian Patent Office, Delhi for the development of a new formulation. This unique formulation represents a significant leap forward in the treatment of Thalassemia, promising to improve patient outcomes and offer a better quality of life.
